ENPICOM introduces IGX Platform for powerful liability prediction to de-risk antibody development
The bioinformatics software company ENPICOM showed the capabilities of its new IGX Platform, at the recent Biologics UK conference. The platform accurately annotates exposed liabilities, performs structural modelling of antibodies at scale, and determines developability profiles using customizable penalties. This major development allows researchers to improve their candidate selection by making accurate developability predictions for […]
